Teresita Gomez, MD
Sports Medicine · Campbell
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 2 carriers
- Office
- 1
Offices
1 location · University Healthcare Alliance · 334 clinicians in this group
Looking this up.
Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.
Plans that list them
14 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gomez’s office at (408) 357-1410 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A173769 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · Pontifical Catholic University of Chile Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$31,379
Medicare paid this office $31,379 for 82 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 44 | $7,226 | $86 |
| New patient visit (45+ min) | 36 | $5,692 | $158 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 54 | $4,490 | $63 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 27 | $4,034 | $103 |
| New patient visit (30+ min) | 36 | $3,675 | $102 |
See all 7 services
| Short return visit (20+ min) | 44 | $7,226 | $86 |
| New patient visit (45+ min) | 36 | $5,692 | $158 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 54 | $4,490 | $63 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 27 | $4,034 | $103 |
| New patient visit (30+ min) | 36 | $3,675 | $102 |
| Injection of trigger points, 1-2 muscles | 13 | $949 | $50 |
| Injection, methylprednisolone acetate, 1 mg | 21 | $97 | None |
Who their Medicare patients are
82 Original Medicare patients in 2024. Average age 74 · Women 49% · Also on Medicaid 17% · Health risk score 1.04. At or below the middle of the specialty; the typical sports medicine clinician is at 1.05.
Conditions among them: High blood pressure 62% · Coronary heart disease 27% · Diabetes 24% · Depression 16% · Chronic kidney disease 13%.
The office billed $130,696, Medicare allowed $39,581 and paid $31,379; for 1,866 services of 15 kinds; $3,840 of it was for drugs given in the office and $27,539 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$50,845 in 2024
Medicaid paid $50,845 for 645 billed services this clinician did in 2024, up to 117 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 205 | $46,699 |
| Short return visit (20+ min) | 421 | $4,050 |
| Short return visit | 19 | $96 |
| 2024 | 645 | 3 | 117 | $50,845 |
| 2023 | 3,138 | 7 | 142 | $236,917 |
| 2022 | 426 | 5 | 80 | $31,007 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,063 | $227,046 |
| Short return visit (20+ min) | 1,596 | $7,081 |
| Return visit (30+ min) | 385 | $2,330 |
| Chronic care management services with the following required elements: multiple (two or more) chronic conditions expected to last at least 12 months, or until the death of the patient, chronic conditions that place the patient at significant risk of death, acute exacerbation/decompensation, or functional decline, comprehensive care plan established, implemented, revised, or monitored; first 20 minutes of clinical staff time directed by a physician or other qualified health care professional, per calendar month. | 32 | $429 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 18 | $19 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 21 | $8 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 23 | $3 |
2022
| Clinic visit/encounter, all-inclusive | 144 | $30,540 |
| Short return visit (20+ min) | 134 | $449 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 16 | $18 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 30 | $0 |
| Return visit (30+ min) | 102 | $0 |
Drugs they prescribed that Part D paid
$38,720
Pharmacies billed $38,720 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
339 generic and fewer than 11 brand-name prescriptions · $38,720 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 55 | $425 | $8 |
| Lisinopril | 25 | $122 | $5 |
| Amlodipine Besylate | 22 | $116 | $5 |
| Metformin | 24 | $110 | $5 |
| Celecoxib | 11 | $87 | $8 |
See all 7 drugs
| Atorvastatin | 55 | $425 | $8 |
| Lisinopril | 25 | $122 | $5 |
| Amlodipine Besylate | 22 | $116 | $5 |
| Metformin | 24 | $110 | $5 |
| Celecoxib | 11 | $87 | $8 |
| Losartan | 17 | $82 | $5 |
| Hydrochlorothiazide | 14 | $53 | $4 |
Year by year
| 2024 | 407 | 90 | None | None | $38,720 |
| 2023 | 1,376 | 177 | 1% (16) | 15% | $178,942 |
| 2022 | 104 | 61 | None | None | $6,713 |
| 2021 | 166 | 26 | 0% (0) | 26% | $14,503 |
| 2020 | 30 | 13 | 0% (0) | None | $2,154 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 30 drugs
| Trulicity | 34 | $33,333 | $980 |
| Atorvastatin | 106 | $2,573 | $24 |
| Metformin | 73 | $1,150 | $16 |
| Albuterol Sulfate Hfa | 31 | $1,111 | $36 |
| Diclofenac | 48 | $1,082 | $23 |
| Amlodipine Besylate | 80 | $1,065 | $13 |
| Tamsulosin | 19 | $1,027 | $54 |
| Pravastatin | 24 | $860 | $36 |
| Metoprolol | 29 | $833 | $29 |
| Losartan | 44 | $734 | $17 |
| Levothyroxine | 26 | $670 | $26 |
| Lisinopril | 61 | $644 | $11 |
| Gabapentin | 34 | $540 | $16 |
| Enalapril Maleate | 13 | $506 | $39 |
| Hydrocodone-Acetaminophen | 14 | $393 | $28 |
| Fluticasone Propionate | 31 | $348 | $11 |
| Sertraline | 13 | $341 | $26 |
| Alendronate | 22 | $338 | $15 |
| Omeprazole | 30 | $303 | $10 |
| Celecoxib | 14 | $237 | $17 |
| Atenolol | 13 | $208 | $16 |
| Famotidine | 21 | $198 | $9 |
| Hydrochlorothiazide | 37 | $189 | $5 |
| Metoprolol | 11 | $179 | $16 |
| Simvastatin | 30 | $164 | $5 |
| Glipizide | 15 | $154 | $10 |
| Triamcinolone Acetonide | 11 | $135 | $12 |
| Furosemide | 13 | $113 | $9 |
| Naproxen | 13 | $77 | $6 |
| Ibuprofen | 12 | $58 | $5 |
2021: 4 drugs
| Novolin R | 11 | $1,698 | $154 |
| Atorvastatin | 14 | $195 | $14 |
| Metformin | 11 | $113 | $10 |
| Amlodipine Besylate | 11 | $93 | $8 |
Professional record
- NPI
- 1174020192
- Licence
- CA A173769California A173769: Current · expires 2027-07-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207QS0010X (207QS0010X); Family medicine (207Q00000X)
- Mailing address
- 50 E Hamilton Ave Ste 120, Campbell, CA, 95008
- NPI first listed
- 2018-04-06
- NPI last updated
- 2025-06-05
- NPI record certified
- 2025-06-05
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 757 Westwood Plz, Los Angeles, CA, 90095 · 1333 Meridian Ave, San Jose, CA, 95125 · 1642 E Capitol Expy, San Jose, CA, 95121 · 455 Oconnor Dr Ste 200, San Jose, CA, 95128